Join
Live feed
·
INSIDERFilingvia Quantisnow
Coherus Oncology Inc. logo

Director Wahlstrom Mats was granted 30,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CHRS· Coherus Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CHRS (Coherus Oncology Inc.) and more on Quantisnow.

Director Wahlstrom Mats was granted 30,000 shares (SEC Form 4) | Quantisnow